SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as traders brace for a July 29th FDA Advisory Committee meeting, with significant community debate focused on whether the FDA will approve deramiocel for both skeletal and cardiac function or restrict it to a narrower cardiomyopathy label. Investors are closely monitoring briefing documents and potential regulatory outcomes, as high short interest and anticipation of a binary catalyst continue to drive intense volatility in the stock.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is experiencing significant volatility following the appointment of a new CEO and news of sNDA submissions for its Duchenne muscular dystrophy therapies, fueling intense community debate over leadership changes and institutional sentiment. Investors remain divided between optimism regarding potential buyout scenarios and frustration over the stock's long-term underperformance.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum is trending as investors weigh an expanded partnership with AT&T and a recent move to the Nasdaq against broader macro-driven volatility in speculative high-beta tech. While the community is actively debating the stock's valuation and the timing of commercial quantum adoption, many are focused on whether upcoming earnings will demonstrate that these strategic catalysts are successfully translating into revenue growth.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. (CRML) is currently trending as investors weigh its potential as a strategic Western supplier of critical rare earth elements against concerns over project timelines and share dilution. While community sentiment remains divided between bullish long-term outlooks on the Tanbreez deposit's assets and frustration over recent stock volatility, traders are closely monitoring potential infrastructure developments and government-backed initiatives within the critical minerals sector.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigetti Computing is trending as investors react to new federal executive orders aimed at accelerating U.S. quantum technology leadership and secure data migration. The community is actively debating the stock's long-term potential versus concerns over high cash burn rates, recent insider selling, and the reliability of government-linked catalysts.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is trending as investors react to a negative CHMP opinion in Europe, though community sentiment remains resilient due to the drug's established U.S. FDA approval and upcoming reimbursement catalysts like the J-code activation. Discussions are heavily focused on the company's planned appeal, the potential for an independent expert group review to overturn the decision, and the belief that the stock's recent volatility is being driven by short-term sentiment rather than underlying fundamentals.

Litecoin is a decentralized, peer-to-peer digital currency designed to enable instant, near-zero cost payments to individuals and merchants worldwide. As an open-source global payment network that functions independently of central banks or intermediaries, its main value proposition lies in providing a scarce digital asset with a fixed maximum supply of 84 million tokens.  The network operates using a Proof of Work mechanism where computers solve complex puzzles to confirm transactions and secure the blockchain. It is distinguished by a block generation time of 2.5 minutes, which allows for faster transaction confirmations and a higher total throughput than earlier protocols. Key technical features include the Scrypt hashing algorithm, which promotes wider network participation, and MimbleWimble Extension Blocks, which improve user privacy by allowing transaction details to be hidden.  The LTC token is used for settling global payments, executing microtransactions through smaller units called litoshis, and diversifying digital portfolios with a highly liquid asset. New tokens are issued to miners as rewards for verifying blocks, though these rewards undergo a halving event approximately every four years to strictly control inflation. This process ensures the ledger maintains immutability, meaning records cannot be changed once they are saved to the global network.  Created by former Google engineer Charlie Lee, the project is supported by the Litecoin Foundation, a non-profit organization dedicated to ecosystem adoption. Unlike many venture-backed projects, it is maintained by a decentralized community of independent developers and a global network of miners. The project has seen recent institutional adoption, with entities like Lite Strategy and Luxxfolio Holdings adding significant amounts of LTC to their corporate treasuries as of late 2025.

Litecoin

Litecoin is trending as investors debate whether the recent price action near key resistance levels signals a long-awaited macro bottom or a trap for the bulls. The community remains deeply polarized, with many users actively discussing the coin's utility and institutional adoption while others express frustration over its prolonged period of sideways performance compared to the broader crypto market.

Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.

Legend Biotech Corp - ADR

Legend Biotech

Legend Biotech is trending following a significant leadership transition as the company navigates ongoing market volatility and mixed reactions to its flagship product performance. Community discourse is heavily focused on whether this disruption and current price weakness signal a potential buyout opportunity or suggest underlying structural issues within the organization.

Forte Biosciences, Inc. is a biopharmaceutical company, which engages in the provision of dermatology products and services. Its lead product includes FB-401, which is a live biotherapeutic for the treatment of inflammatory skin disease, including pediatric and adult patients with atopic dermatitis. The company was founded by Paul A. Wagner on May 3, 2017 and is headquartered in Dallas, TX.

Forte Biosciences Inc

Forte Biosciences is surging following the announcement of a $53 million private placement, which has triggered heavy volume and intense speculation among traders. The community is actively debating the stock's massive single-day gains, with some participants expressing caution regarding potential dilution while others remain optimistic about the company's clinical pipeline.

ProShares Trust II - ProShares Ultra Bloomberg Crude Oil 2x Shares

ProShares Ultra Bloomberg Crude Oil

ProShares Ultra Bloomberg Crude Oil (UCO) is trending as traders closely monitor fluctuating geopolitical tensions, specifically developments surrounding US-Iran diplomatic efforts and potential disruptions in the Strait of Hormuz. The community remains divided, with active debates centered on whether current supply constraints support a bullish outlook or if potential peace agreements and increasing renewable energy adoption will trigger a significant correction in crude prices.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Investors are Bullish on Solaris Energy Infrastructure (SEI)?

Why Investors are Bullish on Solaris Energy Infrastructure (SEI...

NOV Stock Rallies 49% in a Year: Time to Buy or Move On?

NOV's technology gains, rising earnings estimates, strong backlog and shareholder returns strengthen its long-term outlook despite trailing some peers.

Solaris Energy Infrastructure Schedules Second Quarter 2026 Results Conference Call

Solaris Energy Infrastructure, Inc. (NYSE:SEI) (Solaris or the Company) announced today that it will host a conference call to discuss its second quarter 2026 results on Thursday, August 6, 2026 at 8:00 a.m. Central Time (9:00 a.m. Eastern Time). Solaris will issue its second quarter earnings...

SEI Stock Jumps 5% After-Hours As S&P 600 Inclusion Sparks Buying

Equity

SEI will replace Catalyst Pharmaceuticals in the index, effective prior to the open of trading on Wednesday, July 15.


Solaris Energy Infrastructure Set to Join S&P SmallCap 600

Solaris Energy Infrastructure Set to Join S&P SmallCap 600 Solaris Energy Infrastructure Set to Join S&P SmallCap 600 PR Newswire NEW YORK, July 9, 2026 NEW YORK, July 9, 2026 /PRNewswire/ -- Solaris Energy Infrastructure Inc. (NYSE: SEI) will replace Catalyst Pharmaceuticals Inc. (NASD: CPRX) in...

Solaris Energy's $55M GESA Deal Expands Power Services Portfolio

SEI is acquiring GESA in a $55 million cash-and-stock deal to strengthen its full-cycle power services and accelerate long-term growth.

Solaris Energy Infrastructure Acquires Leading Global Provider of Full Cycle Power Generation Operations, Maintenance, and Technical Solutions

Solaris Energy Infrastructure, Inc. (NYSE:SEI) (Solaris or the Company), today announced the acquisition of Global Energy Services Alliance, Inc. (GESA), a full cycle power generation service provider. GESA was formed via the combination of Baseload Power, a U.S.-based provider of power generation...

Do Options Traders Know Something About Solaris Energy Stock We Don't?

Investors need to pay close attention to SEI stock based on the movements in the options market lately.

Solaris Energy Infrastructure About To Put More Money In Your Pocket (SEI)

Looking at the universe of stocks we cover at Dividend Channel, on 6/2/26, Solaris Energy Infrastructure Inc (Symbol: SEI) will trade ex-dividend, for its quarterly dividend of $0.12, payable on 6/12/26. As a percentage of SEI's recent stock price of $67.98, this dividend works...

Solaris Energy Infrastructure, Inc. (SEI): Leopold Aschenbrenner Trims Position

Solaris Energy Infrastructure, Inc. (SEI): Leopold Aschenbrenner Trims Position...

Solaris Energy Infrastructure, Inc. is a holding company, which engages in the manufacture of patented mobile proppant management systems that unload, store, and deliver proppant to oil and natural gas well sites. The firm's products include Mobile Proppant and Mobile Chemical Management Systems, and Inventory Management Software. It operates through the following segments: Solaris Power Solutions and Solaris Logistics Solutions. The Solaris Power Solutions segment includes delivery of power generation, control, and distribution solutions. The Solaris Logistics Solutions segment designs and manufactures specialized equipment that enables the efficient management of raw materials used in the completion of oil and natural gas wells. The company was founded by William A. Zartler in 2014 and is headquartered in Houston, TX.

Solaris Energy Infrastructure Inc. - Ordinary Shares - Class A

Neutral Sentiment

U.S. - Iran negotiations

Earnings

FOMC meeting

Other (drop a comment)

This week brings a Federal Reserve rate decision, Q2 GDP and PCE inflation data, and earnings from $MSFT, $META, $AAPL, and $AMZN. What will be the biggest driver of the market this week? Vote and explain your reasoning in the comments.

What will be the main driver of the market this week? 
 
Explain your reasoning in the comments.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	$0.38	--	--	N/A
Q1 '26	$0.33	$0.30	-8.40%	MISSED
Q4 '25	$0.30	-$0.04	-113.15%	MISSED
Q3 '25	$0.34	$0.31	-9.82%	MISSED
Q2 '25	$0.22	$0.30	36.59%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

SEISolaris Energy Infrastructure Inc. - Ordinary Shares - Class A

Upcoming Earnings: Q2 '26

Historical Earnings

Latest SEI News